Revenio sells eye-testing devices and software, and demand is rising as more people need screening for chronic eye diseases. The next leg of growth may come from new screening products and AI-powered tools that add more repeat software revenue, but tariffs, regulators, and tougher local rivals could slow the story.Read more
Revenio is turning into a broader eye-testing platform after buying Visionix, giving it more ways to sell into everyday eye exams and long-term disease monitoring. The upside hinges on whether the company can roll out more AI-assisted screening and successfully blend the two product lines without debt and integration headaches getting in the way.Read more
Catalysts About Revenio Group Oyj Revenio Group Oyj focuses on ophthalmic diagnostic devices and related software, with a growing presence in fundus imaging, tonometry and eye screening solutions. What are the underlying business or industry changes driving this perspective?Read more
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used by veterinarians, ophthalmologists and other personnel to measure intraocular pressure in animal patients. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
